Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Oral sodium phosphates: US FDA wants new safety measures

    • 7 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Oral sodium phosphates: US FDA wants new safety measures. React. Wkly. 1233, 1 (2009). https://doi.org/10.2165/00128415-200912330-00001

    Download citation

    Keywords

    • Angiotensin
    • Acute Kidney Injury
    • Mitigation Strategy
    • Safety Measure
    • Labelling Condition